OSTEORPOROSIS DRUG AND CANCER
ANCHOR LEAD: A DRUG USUALLY USED TO MANAGE OSTEOPOROSIS MAY HELP SOME WOMEN WITH BREAST CANCER, ELIZABETH TRACEY REPORTS.
Bisphosphonates are a class of medications used mostly to manage osteoporosis. They’ve also been shown to help reduce fractures in people who have had cancer spread to their bones. Now a new study has demonstrated that they may help reduce recurrence of breast cancer in some women with the disease. Ben Park, a breast cancer expert at Johns Hopkins, comments.
PARK: This one was the first really in a large scale, prospective fashion looking at this subgroup of women to see whether or not there is benefit in reducing disease recurrence with bisphosponate therapy, and it turns out there was. It’s not a huge benefit but statistically significant and as good as any other therapeutic, adjuvant chemotherapy in the past, and so this adds another weapon to our armamentarium to try to prevent breast cancer recurrence. :24
Park says it remains to be seen how broadly bisphosphonates may be used in women with breast cancer, as well as how they may be integrated with other therapies following surgery. I’m Elizabeth Tracey reporting.